EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Benefits beyond health in the willingness to pay for a quality-adjusted life-year

Linda M de Vries, Werner B F Brouwer, Pieter H M van Baal

The European Journal of Health Economics · 2025

DOI: 10.1007/s10198-024-01726-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The European Journal of Health Economics, 2025. Verfasst von Linda M de Vries und 2 weiteren Autor:innen. Beteiligte Einrichtung: Erasmus School of Health Policy and Management, Department of Health Economics, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The …. Hauptthemen laut MEDLINE: Quality-Adjusted Life Years, Cost-Benefit Analysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GlaxoSmithKline, AbbVie, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adopting a societal perspective in cost-effectiveness analysis (CEA) requires including all societal costs and benefits even if they fall outside of the realm of health and healthcare. While some benefits are not explicitly included, they might be implicitly included when people value quality-adjusted life-years (QALYs) in monetary terms. An example is utility of consumption (UoC) which has played a crucial role in discussions regarding the welfare economic underpinnings of CEA. This study investigates whether people consider elements beyond health when valuing QALYs monetarily and the influence of inclusion on this value. A Willingness to Pay (WTP) experiment was administered among the general public in which people were asked to assign monetary values to QALYs. Our results show that (stated) UoC increases with quality of life but that instructing people to consider UoC does not impact their monetary valuation of the QALY. Furthermore, many respondents consider elements beyond health when valuing QALYs but the impact on the monetary value of a QALY is limited. These findings suggest that these elements are currently not (adequately) captured in CEA. Findings also illustrate that it is difficult to isolate health from non-health benefits and to consistently capture these in CEA. With that, reconciling CEA with welfare economics remains challenging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality-Adjusted Life YearsCost-Benefit AnalysisHumansMaleFemaleMiddle AgedAdultQuality of LifeAgedHealth StatusYoung Adult

Stichwörter der Autor:innen

Cost-effectiveness analysisQALYSocietal perspectiveUtility of consumptionWillingness to pay

Autor:innen und Institutionen

  • Erasmus School of Health Policy and Management, Department of Health Economics, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands. l.m.devries@eshpm.eur.nl.
  • Erasmus School of Health Policy and Management, Department of Health Economics, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands.

Förderung

  • GlaxoSmithKline
  • AbbVie
  • AstraZeneca

Zitieren

APA

de Vries, L. M., Brouwer, W. B. F., & van Baal, P. H. M. (2025). Benefits beyond health in the willingness to pay for a quality-adjusted life-year. The European Journal of Health Economics. https://doi.org/10.1007/s10198-024-01726-7

Vancouver

de Vries LM, Brouwer WBF, van Baal PHM. Benefits beyond health in the willingness to pay for a quality-adjusted life-year. The European Journal of Health Economics. 2025. doi:10.1007/s10198-024-01726-7

BibTeX
@article{deVries2025,
  author = {de Vries, Linda M and Brouwer, Werner B F and van Baal, Pieter H M},
  title = {Benefits beyond health in the willingness to pay for a quality-adjusted life-year},
  journal = {The European Journal of Health Economics},
  year = {2025},
  doi = {10.1007/s10198-024-01726-7}
}
Kostenlos starten →